Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

European Union support for the Lebanese Healthcare System reaches €173 million

18 December 2018 - The European Union has renewed its commitment to strengthen the Lebanese health care system and secure access to chronic medications, vaccines and essential medical commodities to the most vulnerable population in Lebanon. Through an additional contribution of 19 million Euro from the EU Regional Trust Fund in response to the Syrian crisis, UNICEF and WHO will be able to support to people in need living in Lebanon by ensuring provision of primary healthcare services and strengthening the health system.
 
The additional funding was announced today during a joint press conference headed by the Minister of Public Health, Ghassan Hasbani, EU Ambassador Christina Lassen, WHO representative Dr. Imane Shankiti, and UNICEF Representative, Tanya Chapuisat. The donation is part of a package of support of 173 million Euro which the European Union has invested in the health sector to strengthen the system and to help meet the basic health needs of both Lebanese citizens and Syrian refugees in a time of great pressure on service delivery and health infrastructure.
 
“We thank the commitment of the European Union and the support of the World Health Organization and UNICEF in strengthening the healthcare system to meet the needs of both Lebanese and Syrian refugees,” said Minister Hasbany.
 
EU Ambassador Lassen highlighted that "the projects we are launching today are part of a 173 million Euro health package that includes primary and secondary healthcare and aims at achieving quality, affordable and accessible health services for everyone in need in Lebanon".
 
“The generous support of the EU to the health system has sealed a long-standing partnership between the MOPH, WHO and UNICEF, and ensured that health services were of good quality, and that outbreaks and health risks are identified and acted upon early enough” said Imane Shankiti, WHO representative. “Reinforcing the health system capacity, along with filling critical health services with EU support ensured that no patient in need for health care was left behind”.
 
“The strong partnership we have with the EU, the ministry of Public Health and WHO has ensured that every child in Lebanon has access to quality vaccines to remain safe from outbreaks of preventable diseases,” said Tanya Chapuisat, UNICEF Representative to Lebanon. “Through EU funding we are able to save lives and strengthen systems to shape a better future for children”.
 
 
    ...
    75
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
N05AF05 CLOPIXOL DEPOT B Zuclopenthixol decanoate - 200mg/ml 200mg/ml Injectable solution 512,004 L.L
B05XA03 HYPOTONIC SALINE G Sodium chloride - 0.45% 0.45% Injectable solution 149,393 L.L
J01XX08 ZERSA G Linezolide - 600mg/300ml 600mg/300ml Injectable solution 3,303,165 L.L
L01BB05 FLUDARABINE PHOSPHATE NEAPOLIS G Fludarabine Dihydrogenophosphate - 50mg/2ml 50mg/2ml Injectable solution 4,031,528 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
N05AF05 CLOPIXOL ACUPHASE B Zuclopenthixol acetate - 100mg/2ml 100mg/2ml Injectable solution 857,372 L.L
B05XA03 HYPOTONIC SALINE G Sodium chloride - 0.45% 0.45% Injectable solution 163,184 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
A03BB01 ANTIPAN G Hyoscine N butylbromide - 20mg/ml Injectable solution 355,798 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 133,856 L.L
C07AG01 LABETALOL HYDROCHLORIDE INJECTION G Labetalol HCl - 100mg/20ml 100mg/20ml Injectable solution 2,955,110 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
A03BB01 ANTIPAN G Hyoscine N butylbromide - 20mg/ml Injectable solution 2,557,140 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 149,393 L.L
L01BC01 ALEXAN G Cytarabine - 100mg/5ml 100mg/5ml Injectable solution 388,370 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
A03BB01 SCOBUREN G Butylscopolamine bromide - 20mg/ml 20mg/ml Injectable solution 370,901 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 163,184 L.L
L01BC01 ALEXAN G Cytarabine - 1,000mg/20ml 1,000mg/20ml Injectable solution 2,848,946 L.L
L04AB04 ABRILADA BioTech Adalimumab - 40mg 40mg Injectable solution 40,259,574 L.L
N02BE01 PARACETAMOL PANPHARMA G Paracetamol - 10mg/ml 10mg/ml Injectable solution 1,959,322 L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution L.L
A03BB01 SCOPINAL G Butylscopolamine bromide - 20mg/ml 20mg/ml Injectable solution 178,731 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 176,974 L.L
L01BC01 CYTU G Cytarabine - 1000mg/10ml 1000mg/10ml Injectable solution 2,230,779 L.L
L04AB04 ABRILADA BioTech Adalimumab - 40mg 40mg Injectable solution 40,259,574 L.L
N02BE01 MAKOACHE G Paracetamol - 1000mg/100ml 10mg/ml Injectable solution 1,403,867 L.L
A03BB01 ? HYOSCINE BUTYLBROMIDE G Hyoscine butylbromide - 20mg/ml 20mg/ml Injectable solution 70,392 L.L
B05BB01 LACTATED RINGER'S G Sodium lactate - 0.31g/100ml, Calcium chloride, 2H2O - 0.02g/100ml, Potassium chloride - 0.03g/100ml, Sodium chloride - 0.598g/100ml Injectable solution 147,095 L.L
    ...
    75
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025